▶ 調査レポート

世界のHIV-AIDS検査市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global HIV-AIDS Testing Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のHIV-AIDS検査市場規模・現状・予測(2021年-2027年) / Global HIV-AIDS Testing Market Size, Status and Forecast 2021-2027 / QYR2104Z2865資料のイメージです。• レポートコード:QYR2104Z2865
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、130ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、HIV-AIDS検査のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(キット、試薬、器具、その他)、用途別市場規模(病院、私立診断研究所、学術・研究所、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・HIV-AIDS検査の市場動向
・企業の競争状況、市場シェア
・HIV-AIDS検査の種類別市場規模(キット、試薬、器具、その他)
・HIV-AIDS検査の用途別市場規模(病院、私立診断研究所、学術・研究所、その他)
・HIV-AIDS検査の北米市場規模2016-2027(アメリカ、カナダ)
・HIV-AIDS検査のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・HIV-AIDS検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・HIV-AIDS検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・HIV-AIDS検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Affymetrix、Beckman Coulter/Danaher、Becton Dickinson、bioMerieux、Bio-Rad、Cepheid、Diamedix、DiaSorin、Eiken Chemical、Elitech Group、Enzo Biochem、Fujirebio、Lonza、Roche、Scienion、Sequenom、SeraCare、Siemens、Takara Bio)
・結論

HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease.

HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue.

Market Analysis and Insights: Global HIV-AIDS Testing Market
The global HIV-AIDS Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HIV-AIDS Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HIV-AIDS Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HIV-AIDS Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HIV-AIDS Testing market.

Global HIV-AIDS Testing Scope and Market Size
HIV-AIDS Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HIV-AIDS Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Kits and Reagents
Instruments
Others

Segment by Application
Hospitals
Private Diagnostics Laboratories
Academic and Research Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Becton Dickinson
bioMerieux
Enzo Biochem
Fujirebio
Lonza
Roche
Scienion
Sequenom
SeraCare

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV-AIDS Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Kits and Reagents
1.2.3 Instruments
1.2.4 Others
1.3 Market by Application
1.3.1 Global HIV-AIDS Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Private Diagnostics Laboratories
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global HIV-AIDS Testing Market Perspective (2016-2027)
2.2 HIV-AIDS Testing Growth Trends by Regions
2.2.1 HIV-AIDS Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HIV-AIDS Testing Historic Market Share by Regions (2016-2021)
2.2.3 HIV-AIDS Testing Forecasted Market Size by Regions (2022-2027)
2.3 HIV-AIDS Testing Industry Dynamic
2.3.1 HIV-AIDS Testing Market Trends
2.3.2 HIV-AIDS Testing Market Drivers
2.3.3 HIV-AIDS Testing Market Challenges
2.3.4 HIV-AIDS Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top HIV-AIDS Testing Players by Revenue
3.1.1 Global Top HIV-AIDS Testing Players by Revenue (2016-2021)
3.1.2 Global HIV-AIDS Testing Revenue Market Share by Players (2016-2021)
3.2 Global HIV-AIDS Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HIV-AIDS Testing Revenue
3.4 Global HIV-AIDS Testing Market Concentration Ratio
3.4.1 Global HIV-AIDS Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV-AIDS Testing Revenue in 2020
3.5 HIV-AIDS Testing Key Players Head office and Area Served
3.6 Key Players HIV-AIDS Testing Product Solution and Service
3.7 Date of Enter into HIV-AIDS Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 HIV-AIDS Testing Breakdown Data by Type
4.1 Global HIV-AIDS Testing Historic Market Size by Type (2016-2021)
4.2 Global HIV-AIDS Testing Forecasted Market Size by Type (2022-2027)

5 HIV-AIDS Testing Breakdown Data by Application
5.1 Global HIV-AIDS Testing Historic Market Size by Application (2016-2021)
5.2 Global HIV-AIDS Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America HIV-AIDS Testing Market Size (2016-2027)
6.2 North America HIV-AIDS Testing Market Size by Type
6.2.1 North America HIV-AIDS Testing Market Size by Type (2016-2021)
6.2.2 North America HIV-AIDS Testing Market Size by Type (2022-2027)
6.2.3 North America HIV-AIDS Testing Market Size by Type (2016-2027)
6.3 North America HIV-AIDS Testing Market Size by Application
6.3.1 North America HIV-AIDS Testing Market Size by Application (2016-2021)
6.3.2 North America HIV-AIDS Testing Market Size by Application (2022-2027)
6.3.3 North America HIV-AIDS Testing Market Size by Application (2016-2027)
6.4 North America HIV-AIDS Testing Market Size by Country
6.4.1 North America HIV-AIDS Testing Market Size by Country (2016-2021)
6.4.2 North America HIV-AIDS Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe HIV-AIDS Testing Market Size (2016-2027)
7.2 Europe HIV-AIDS Testing Market Size by Type
7.2.1 Europe HIV-AIDS Testing Market Size by Type (2016-2021)
7.2.2 Europe HIV-AIDS Testing Market Size by Type (2022-2027)
7.2.3 Europe HIV-AIDS Testing Market Size by Type (2016-2027)
7.3 Europe HIV-AIDS Testing Market Size by Application
7.3.1 Europe HIV-AIDS Testing Market Size by Application (2016-2021)
7.3.2 Europe HIV-AIDS Testing Market Size by Application (2022-2027)
7.3.3 Europe HIV-AIDS Testing Market Size by Application (2016-2027)
7.4 Europe HIV-AIDS Testing Market Size by Country
7.4.1 Europe HIV-AIDS Testing Market Size by Country (2016-2021)
7.4.2 Europe HIV-AIDS Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific HIV-AIDS Testing Market Size (2016-2027)
8.2 Asia-Pacific HIV-AIDS Testing Market Size by Type
8.2.1 Asia-Pacific HIV-AIDS Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HIV-AIDS Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HIV-AIDS Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific HIV-AIDS Testing Market Size by Application
8.3.1 Asia-Pacific HIV-AIDS Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HIV-AIDS Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HIV-AIDS Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific HIV-AIDS Testing Market Size by Region
8.4.1 Asia-Pacific HIV-AIDS Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HIV-AIDS Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America HIV-AIDS Testing Market Size (2016-2027)
9.2 Latin America HIV-AIDS Testing Market Size by Type
9.2.1 Latin America HIV-AIDS Testing Market Size by Type (2016-2021)
9.2.2 Latin America HIV-AIDS Testing Market Size by Type (2022-2027)
9.2.3 Latin America HIV-AIDS Testing Market Size by Type (2016-2027)
9.3 Latin America HIV-AIDS Testing Market Size by Application
9.3.1 Latin America HIV-AIDS Testing Market Size by Application (2016-2021)
9.3.2 Latin America HIV-AIDS Testing Market Size by Application (2022-2027)
9.3.3 Latin America HIV-AIDS Testing Market Size by Application (2016-2027)
9.4 Latin America HIV-AIDS Testing Market Size by Country
9.4.1 Latin America HIV-AIDS Testing Market Size by Country (2016-2021)
9.4.2 Latin America HIV-AIDS Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa HIV-AIDS Testing Market Size (2016-2027)
10.2 Middle East & Africa HIV-AIDS Testing Market Size by Type
10.2.1 Middle East & Africa HIV-AIDS Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HIV-AIDS Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HIV-AIDS Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa HIV-AIDS Testing Market Size by Application
10.3.1 Middle East & Africa HIV-AIDS Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HIV-AIDS Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HIV-AIDS Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa HIV-AIDS Testing Market Size by Country
10.4.1 Middle East & Africa HIV-AIDS Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HIV-AIDS Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott HIV-AIDS Testing Introduction
11.1.4 Abbott Revenue in HIV-AIDS Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix HIV-AIDS Testing Introduction
11.2.4 Affymetrix Revenue in HIV-AIDS Testing Business (2016-2021)
11.2.5 Affymetrix Recent Development
11.3 Beckman Coulter/Danaher
11.3.1 Beckman Coulter/Danaher Company Details
11.3.2 Beckman Coulter/Danaher Business Overview
11.3.3 Beckman Coulter/Danaher HIV-AIDS Testing Introduction
11.3.4 Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2016-2021)
11.3.5 Beckman Coulter/Danaher Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Details
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson HIV-AIDS Testing Introduction
11.4.4 Becton Dickinson Revenue in HIV-AIDS Testing Business (2016-2021)
11.4.5 Becton Dickinson Recent Development
11.5 bioMerieux
11.5.1 bioMerieux Company Details
11.5.2 bioMerieux Business Overview
11.5.3 bioMerieux HIV-AIDS Testing Introduction
11.5.4 bioMerieux Revenue in HIV-AIDS Testing Business (2016-2021)
11.5.5 bioMerieux Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Details
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad HIV-AIDS Testing Introduction
11.6.4 Bio-Rad Revenue in HIV-AIDS Testing Business (2016-2021)
11.6.5 Bio-Rad Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid HIV-AIDS Testing Introduction
11.7.4 Cepheid Revenue in HIV-AIDS Testing Business (2016-2021)
11.7.5 Cepheid Recent Development
11.8 Diamedix
11.8.1 Diamedix Company Details
11.8.2 Diamedix Business Overview
11.8.3 Diamedix HIV-AIDS Testing Introduction
11.8.4 Diamedix Revenue in HIV-AIDS Testing Business (2016-2021)
11.8.5 Diamedix Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Details
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin HIV-AIDS Testing Introduction
11.9.4 DiaSorin Revenue in HIV-AIDS Testing Business (2016-2021)
11.9.5 DiaSorin Recent Development
11.10 Eiken Chemical
11.10.1 Eiken Chemical Company Details
11.10.2 Eiken Chemical Business Overview
11.10.3 Eiken Chemical HIV-AIDS Testing Introduction
11.10.4 Eiken Chemical Revenue in HIV-AIDS Testing Business (2016-2021)
11.10.5 Eiken Chemical Recent Development
11.11 Elitech Group
11.11.1 Elitech Group Company Details
11.11.2 Elitech Group Business Overview
11.11.3 Elitech Group HIV-AIDS Testing Introduction
11.11.4 Elitech Group Revenue in HIV-AIDS Testing Business (2016-2021)
11.11.5 Elitech Group Recent Development
11.12 Enzo Biochem
11.12.1 Enzo Biochem Company Details
11.12.2 Enzo Biochem Business Overview
11.12.3 Enzo Biochem HIV-AIDS Testing Introduction
11.12.4 Enzo Biochem Revenue in HIV-AIDS Testing Business (2016-2021)
11.12.5 Enzo Biochem Recent Development
11.13 Fujirebio
11.13.1 Fujirebio Company Details
11.13.2 Fujirebio Business Overview
11.13.3 Fujirebio HIV-AIDS Testing Introduction
11.13.4 Fujirebio Revenue in HIV-AIDS Testing Business (2016-2021)
11.13.5 Fujirebio Recent Development
11.14 Lonza
11.14.1 Lonza Company Details
11.14.2 Lonza Business Overview
11.14.3 Lonza HIV-AIDS Testing Introduction
11.14.4 Lonza Revenue in HIV-AIDS Testing Business (2016-2021)
11.14.5 Lonza Recent Development
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche HIV-AIDS Testing Introduction
11.15.4 Roche Revenue in HIV-AIDS Testing Business (2016-2021)
11.15.5 Roche Recent Development
11.16 Scienion
11.16.1 Scienion Company Details
11.16.2 Scienion Business Overview
11.16.3 Scienion HIV-AIDS Testing Introduction
11.16.4 Scienion Revenue in HIV-AIDS Testing Business (2016-2021)
11.16.5 Scienion Recent Development
11.17 Sequenom
11.17.1 Sequenom Company Details
11.17.2 Sequenom Business Overview
11.17.3 Sequenom HIV-AIDS Testing Introduction
11.17.4 Sequenom Revenue in HIV-AIDS Testing Business (2016-2021)
11.17.5 Sequenom Recent Development
11.18 SeraCare
11.18.1 SeraCare Company Details
11.18.2 SeraCare Business Overview
11.18.3 SeraCare HIV-AIDS Testing Introduction
11.18.4 SeraCare Revenue in HIV-AIDS Testing Business (2016-2021)
11.18.5 SeraCare Recent Development
11.18 Siemens
.1 Siemens Company Details
.2 Siemens Business Overview
.3 Siemens HIV-AIDS Testing Introduction
.4 Siemens Revenue in HIV-AIDS Testing Business (2016-2021)
.5 Siemens Recent Development
11.20 Takara Bio
11.20.1 Takara Bio Company Details
11.20.2 Takara Bio Business Overview
11.20.3 Takara Bio HIV-AIDS Testing Introduction
11.20.4 Takara Bio Revenue in HIV-AIDS Testing Business (2016-2021)
11.20.5 Takara Bio Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global HIV-AIDS Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Kits and Reagents
Table 3. Key Players of Instruments
Table 4. Key Players of Others
Table 5. Global HIV-AIDS Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global HIV-AIDS Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global HIV-AIDS Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global HIV-AIDS Testing Market Share by Regions (2016-2021)
Table 9. Global HIV-AIDS Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global HIV-AIDS Testing Market Share by Regions (2022-2027)
Table 11. HIV-AIDS Testing Market Trends
Table 12. HIV-AIDS Testing Market Drivers
Table 13. HIV-AIDS Testing Market Challenges
Table 14. HIV-AIDS Testing Market Restraints
Table 15. Global HIV-AIDS Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global HIV-AIDS Testing Market Share by Players (2016-2021)
Table 17. Global Top HIV-AIDS Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV-AIDS Testing as of 2020)
Table 18. Ranking of Global Top HIV-AIDS Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by HIV-AIDS Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players HIV-AIDS Testing Product Solution and Service
Table 22. Date of Enter into HIV-AIDS Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HIV-AIDS Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global HIV-AIDS Testing Revenue Market Share by Type (2016-2021)
Table 26. Global HIV-AIDS Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global HIV-AIDS Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global HIV-AIDS Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global HIV-AIDS Testing Revenue Market Share by Application (2016-2021)
Table 30. Global HIV-AIDS Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global HIV-AIDS Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America HIV-AIDS Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America HIV-AIDS Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America HIV-AIDS Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America HIV-AIDS Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America HIV-AIDS Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America HIV-AIDS Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe HIV-AIDS Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe HIV-AIDS Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe HIV-AIDS Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe HIV-AIDS Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe HIV-AIDS Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe HIV-AIDS Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific HIV-AIDS Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific HIV-AIDS Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific HIV-AIDS Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific HIV-AIDS Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific HIV-AIDS Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific HIV-AIDS Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America HIV-AIDS Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America HIV-AIDS Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America HIV-AIDS Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America HIV-AIDS Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America HIV-AIDS Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America HIV-AIDS Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa HIV-AIDS Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa HIV-AIDS Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa HIV-AIDS Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa HIV-AIDS Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa HIV-AIDS Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa HIV-AIDS Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott HIV-AIDS Testing Product
Table 65. Abbott Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Affymetrix Company Details
Table 68. Affymetrix Business Overview
Table 69. Affymetrix HIV-AIDS Testing Product
Table 70. Affymetrix Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 71. Affymetrix Recent Development
Table 72. Beckman Coulter/Danaher Company Details
Table 73. Beckman Coulter/Danaher Business Overview
Table 74. Beckman Coulter/Danaher HIV-AIDS Testing Product
Table 75. Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 76. Beckman Coulter/Danaher Recent Development
Table 77. Becton Dickinson Company Details
Table 78. Becton Dickinson Business Overview
Table 79. Becton Dickinson HIV-AIDS Testing Product
Table 80. Becton Dickinson Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 81. Becton Dickinson Recent Development
Table 82. bioMerieux Company Details
Table 83. bioMerieux Business Overview
Table 84. bioMerieux HIV-AIDS Testing Product
Table 85. bioMerieux Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 86. bioMerieux Recent Development
Table 87. Bio-Rad Company Details
Table 88. Bio-Rad Business Overview
Table 89. Bio-Rad HIV-AIDS Testing Product
Table 90. Bio-Rad Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 91. Bio-Rad Recent Development
Table 92. Cepheid Company Details
Table 93. Cepheid Business Overview
Table 94. Cepheid HIV-AIDS Testing Product
Table 95. Cepheid Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 96. Cepheid Recent Development
Table 97. Diamedix Company Details
Table 98. Diamedix Business Overview
Table 99. Diamedix Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 100. Diamedix Recent Development
Table 101. DiaSorin Company Details
Table 102. DiaSorin Business Overview
Table 103. DiaSorin HIV-AIDS Testing Product
Table 104. DiaSorin Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 105. DiaSorin Recent Development
Table 106. Eiken Chemical Company Details
Table 107. Eiken Chemical Business Overview
Table 108. Eiken Chemical HIV-AIDS Testing Product
Table 109. Eiken Chemical Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 110. Eiken Chemical Recent Development
Table 111. Elitech Group Company Details
Table 112. Elitech Group Business Overview
Table 113. Elitech Group HIV-AIDS Testing Product
Table 114. Elitech Group Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 115. Elitech Group Recent Development
Table 116. Enzo Biochem Company Details
Table 117. Enzo Biochem Business Overview
Table 118. Enzo Biochem HIV-AIDS Testing Product
Table 119. Enzo Biochem Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 120. Enzo Biochem Recent Development
Table 121. Fujirebio Company Details
Table 122. Fujirebio Business Overview
Table 123. Fujirebio HIV-AIDS Testing Product
Table 124. Fujirebio Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 125. Fujirebio Recent Development
Table 126. Lonza Company Details
Table 127. Lonza Business Overview
Table 128. Lonza HIV-AIDS Testing Product
Table 129. Lonza Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 130. Lonza Recent Development
Table 131. Roche Company Details
Table 132. Roche Business Overview
Table 133. Roche HIV-AIDS Testing Product
Table 134. Roche Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 135. Roche Recent Development
Table 136. Scienion Company Details
Table 137. Scienion Business Overview
Table 138. Scienion HIV-AIDS Testing Product
Table 139. Scienion Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 140. Scienion Recent Development
Table 141. Sequenom Company Details
Table 142. Sequenom Business Overview
Table 143. Sequenom HIV-AIDS Testing Product
Table 144. Sequenom Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 145. Sequenom Recent Development
Table 146. SeraCare Company Details
Table 147. SeraCare Business Overview
Table 148. SeraCare HIV-AIDS Testing Product
Table 149. SeraCare Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 150. SeraCare Recent Development
Table 151. Siemens Company Details
Table 152. Siemens Business Overview
Table 153. Siemens HIV-AIDS Testing Product
Table 154. Siemens Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 155. Siemens Recent Development
Table 156. Takara Bio Company Details
Table 157. Takara Bio Business Overview
Table 158. Takara Bio HIV-AIDS Testing Product
Table 159. Takara Bio Revenue in HIV-AIDS Testing Business (2016-2021) & (US$ Million)
Table 160. Takara Bio Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV-AIDS Testing Market Share by Type: 2020 VS 2027
Figure 2. Kits and Reagents Features
Figure 3. Instruments Features
Figure 4. Others Features
Figure 5. Global HIV-AIDS Testing Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Private Diagnostics Laboratories Case Studies
Figure 8. Academic and Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. HIV-AIDS Testing Report Years Considered
Figure 11. Global HIV-AIDS Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global HIV-AIDS Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global HIV-AIDS Testing Market Share by Regions: 2020 VS 2027
Figure 14. Global HIV-AIDS Testing Market Share by Regions (2022-2027)
Figure 15. Global HIV-AIDS Testing Market Share by Players in 2020
Figure 16. Global Top HIV-AIDS Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV-AIDS Testing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by HIV-AIDS Testing Revenue in 2020
Figure 18. Global HIV-AIDS Testing Revenue Market Share by Type (2016-2021)
Figure 19. Global HIV-AIDS Testing Revenue Market Share by Type (2022-2027)
Figure 20. North America HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America HIV-AIDS Testing Market Share by Type (2016-2027)
Figure 22. North America HIV-AIDS Testing Market Share by Application (2016-2027)
Figure 23. North America HIV-AIDS Testing Market Share by Country (2016-2027)
Figure 24. United States HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe HIV-AIDS Testing Market Share by Type (2016-2027)
Figure 28. Europe HIV-AIDS Testing Market Share by Application (2016-2027)
Figure 29. Europe HIV-AIDS Testing Market Share by Country (2016-2027)
Figure 30. Germany HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific HIV-AIDS Testing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific HIV-AIDS Testing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific HIV-AIDS Testing Market Share by Region (2016-2027)
Figure 40. China HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America HIV-AIDS Testing Market Share by Type (2016-2027)
Figure 48. Latin America HIV-AIDS Testing Market Share by Application (2016-2027)
Figure 49. Latin America HIV-AIDS Testing Market Share by Country (2016-2027)
Figure 50. Mexico HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa HIV-AIDS Testing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa HIV-AIDS Testing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa HIV-AIDS Testing Market Share by Country (2016-2027)
Figure 56. Turkey HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE HIV-AIDS Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 60. Affymetrix Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 61. Beckman Coulter/Danaher Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 62. Becton Dickinson Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 63. bioMerieux Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 64. Bio-Rad Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 65. Cepheid Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 66. Diamedix Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 67. DiaSorin Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 68. Eiken Chemical Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 69. Elitech Group Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 70. Enzo Biochem Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 71. Fujirebio Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 72. Lonza Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 73. Roche Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 74. Scienion Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 75. Sequenom Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 76. SeraCare Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 77. Siemens Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 78. Takara Bio Revenue Growth Rate in HIV-AIDS Testing Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed